Manchester / Berlin / Cambridge / Nutley / Hamburg / /
Company
IgG / Page 52 Bioprocessing Novel Glycosylation Technologies / Glycotope GmbH / Business Development Group / GlycoEngineering Group / /
Country
Germany / United States / United Kingdom / /
Currency
USD / / /
Event
FDA Phase / /
Facility
Roche Institute of Molecular Biology / German Institute of Human Nutrition / /
IndustryTerm
recombinant product / recombinant products / established novel technologies / glycosylation site / biopharmaceutical products / treatment of cancer / biosimilar product / coli product / glycosylation machinery / platform technology / downstream processing / start-up / biopharmaceutical drug products / microbial systems / therapeutic applications / biotechnology production cell line / cellular glycosylation machinery / biopharmaceutical production / /
MedicalCondition
cancer / tumour / /
Organization
MRC Centre for Protein Engineering / Roche Institute of Molecular Biology / German Institute of Human Nutrition / US Federal Reserve / German Cancer Research Centre / Max Delbrueck Centre for Molecular Medicine / Service Unit / /
Person
Biobetters By Hans Baumeister / Steffen Goletz / Hans Baumeister / /
Position
Chief Operating Officer and Head / CEO / CSO and co-founder / Head / /
IPT 09:56